GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...

The Public Health Agency of Canada (PHAC) said this week that it’s leveraged an existing deal with GSK to lock down an initial supply of 500,000 doses of the British drugmaker’s avian ...

For the first time, the U.S. Department of Agriculture has confirmed the presence of H5N1 avian influenza in rats, raising fresh concerns about the virus’s ability to spread among mammals. The ...

Canada has announced a deal to secure 500K doses of GSK’s (NYSE:GSK) avian influenza vaccine for humans as the country steps up efforts to protect at-risk individuals and bolster its federal ...

Feb 19 (Reuters) - The Government of Canada has secured an initial supply of 500,000 doses of GSK's (GSK.L), opens new tab bird flu vaccine to protect individuals most at risk of being exposed to ...

GSK) stands against the other best vaccine stocks to buy now. On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

The US Food and Drug Administration (FDA) approved British drug maker GSK’s combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company ...